Federal prosecutors dropped all charges against former Stryker sales manager David Ard, who was charged with illegally promoting the off-label use of bone growth products and lying to the FDA, according to a MassDevice report.
Mr. Ard was indicted with former Stryker president Mark Philip and other sales managers Jeff Whitaker and William Heppner, whose charges have not been dropped. The indictment alleges the defendant promoted the combined use of the OP-1 Implant, OP-1 Putty and the bone void filler Calstrux, which caused adverse effects, such as irritation and infections, in patients.
Related Articles on Medical Devices:
Covidien Recalls Duet Stapling System After Injuries, Deaths
FDA Misses Deadline in Conflict with Medical Device Makers Over Approval Process
Stryker Federal Criminal Trial Starts in Boston
Mr. Ard was indicted with former Stryker president Mark Philip and other sales managers Jeff Whitaker and William Heppner, whose charges have not been dropped. The indictment alleges the defendant promoted the combined use of the OP-1 Implant, OP-1 Putty and the bone void filler Calstrux, which caused adverse effects, such as irritation and infections, in patients.
Related Articles on Medical Devices:
Covidien Recalls Duet Stapling System After Injuries, Deaths
FDA Misses Deadline in Conflict with Medical Device Makers Over Approval Process
Stryker Federal Criminal Trial Starts in Boston